1. Genomic Analysis and Differential Expression of HMG and S100A Family in Human Arthritis: Upregulated Expression of Chemokines, IL-8 and Nitric Oxide by HMGB1
   Ashok R. Amin et al, 2014, DNA and Cell Biology CrossRef
2. HMGB1 in health and disease
   Rui Kang et al, 2014, Molecular Aspects of Medicine CrossRef
3. Pharmacological Effects of Atorvastatin and Cholesterol and Blood Pressure
   P. Papitha et al, 2016, Current Research in Cardiovascular Pharmacology CrossRef
4. Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis
   Alexandre W. S. de Souza et al, 2014, PLoS ONE CrossRef
5. Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice
   Limin Yang et al, 2020, International Immunopharmacology CrossRef
6. Surgical treatment of a ventricular aneurysm in a patient with essential thrombocythemia complicated by acute myocardial infarction: A case report
   DONG-WEN WANG et al, 2014, Experimental and Therapeutic Medicine CrossRef
7. Postconditioning with rosuvastatin reduces myocardial ischemia-reperfusion injury by inhibiting high mobility group box 1 protein expression
   XIANJIN DU et al, 2014, Experimental and Therapeutic Medicine CrossRef
8. Statin protects endothelial cell against ischemia reperfusion injury through HMGB1/TLR4 pathway
   Zhaowei Zhu et al, 2016, International Journal of Cardiology CrossRef
9. HMGB1 is a promising therapeutic target for acute liver failure
   Tetsu Yamamoto et al, 2017, Expert Review of Gastroenterology & Hepatology CrossRef
10. Short-time pretreatment of rosuvastatin attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression
    Bing Wu et al, 2013, International Journal of Cardiology CrossRef
11. Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China
    Hang Wang et al, 2015, PLOS ONE CrossRef
12. Lipid lowering efficacy of atorvastatin
    Stephen P Adams et al, 2012, Cochrane Database of Systematic Reviews CrossRef
13. The multifunctional protein HMGB1: 50 years of discovery
    Daolin Tang et al, 2023, Nature Reviews Immunology CrossRef
14. Rosuvastatin reduces the pro-inflammatory effects of adriamycin on the expression of HMGB1 and RAGE in rats
    Haiyan Zhang et al, 2018, International Journal of Molecular Medicine CrossRef
15. Atorvastatin for lowering lipids
    Stephen P Adams et al, 2015, Cochrane Database of Systematic Reviews CrossRef
16. High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins
    Alexandre W. S. de Souza et al, 2015, Arthritis Research & Therapy CrossRef
17. Statins: Neurobiological underpinnings and mechanisms in mood disorders
    Adam J. Walker et al, 2021, Neuroscience & Biobehavioral Reviews CrossRef
18. High mobility group box 1 and Dickkopf-related protein 1 as biomarkers of glucose toxicity, atherogenicity, and lower β cell function in patients with type 2 diabetes mellitus
    Hussein Kadhem Al-Hakeim et al, 2022, Growth Factors CrossRef
19. Cardiac Alarmins as Residual Risk Markers of Atherosclerosis under Hypolipidemic Therapy
    Viorel I. Suica et al, 2022, International Journal of Molecular Sciences CrossRef
20. Betulin alleviates on myocardial inflammation in diabetes mice via regulating Siti1/NLRP3/NF-κB pathway
    Yongjin Wen et al, 2020, International Immunopharmacology CrossRef
21. Formulation of solid self-nanoemulsifying drug delivery systems usingN-methyl pyrrolidone as cosolvent
    Anuj G. Agrawal et al, 2015, Drug Development and Industrial Pharmacy CrossRef
22. Association of high mobility group box 1 protein with coronary artery disease
    Necla Benlier et al, 2019, Asian Cardiovascular and Thoracic Annals CrossRef
23. The Role of HMGB1 in Cardiovascular Biology: Danger Signals
    Jingjing Cai et al, 2015, Antioxidants & Redox Signaling CrossRef